Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: German who wrote (59165)	8/14/2000 11:57:50 PM
From: German	Read Replies (1) \| Respond to of 150070

ADVR More DD: compiled by Counsellor at the RagingBull ADVR Board: IDSA 2000 September 7-10 New Orleans home page idsociety.org September 7 - 10, 2000 9/8/00 12:00 PM Product R, a Peptide Regulator of Human Papilloma Virus-18 E7 in HeLa Cells 9/8/00 12:00 PM Inhibition of Adenovirus E1A Expression in HeLa Cells by Product R, a New Anti-Viral Reagent 9/8/00 12:00 - 2:00 pm Poster Discussion Rounds This new session highlights selected poster abstracts detailing new scientific and clinical findings in the following categories. There are no additional fees to attend these sessions; however, preregistration is required as attendance is limited to 15 participants per group. Antifungal Agents and Fungal Infections Group Leader: John Bennett, MD, NIH, Bethesda, MD Bacterial Infections Group Leader: John G. Bartlett, MD, Johns Hopkins Univ. Sch. of Med., Baltimore, MD HIV Infection and AIDS Group Leader: William G. Powderly, MD, Washington Univ., St. Louis, MO Viral Infections (other than HIV) Group Leader: Richard J. Whitely, MD, Univ. of Alabama at Birmingham, Birmingham, Alabama ADVR Due Diligence Company web site adviral.com Current interview with Dr. Hirschman ceocast.com from 7/6/2000 – register for free International AIDS conference in South Africa aids2000.com News releases "A Big Home For Big Dreams" July 17, 2000 Advanced Viral Research Corp. cover story in The Journal News Business Section nyjournalnews.com Advanced Viral Research Corp. Triples Size of Research and Development Facilities biz.yahoo.com PR on CEO’s interview biz.yahoo.com Advanced Viral Research Corp. Cites Influence of 'Product R' On Opportunistic Infections biz.yahoo.com Advanced Viral Research Corp. to Present At 38th Annual Meeting of the Infectious Diseases Society of America biz.yahoo.com Corporate Profile biz.yahoo.com Antiviral From Advanced Viral Research Corp. Inhibits Production of a Key Cervical Cancer-Causing Protein of the Human Papilloma Virus biz.yahoo.com Antiviral from Advanced Viral Research Corp. Inhibits CCR5 Cell Receptor for HIV nolanmadson.com Title: ASM MEETING: Reticulose Stimulates Immune System Without Increasing HIV Viral Load docguide.com ( BW)(NY-ADVANCED-VIRAL)(ADVR) Advanced Viral Research Corp. Receives Approval in Argentina for Human Clinical Studies With "Substance R" fitness.guidesmart.com Controlled Trial of a New Non-Toxic Drug, Reticulose, in the Treatment of Patients with HIV/AIDS dev.asmusa.org Patient Awareness of Treatment Options Fuels Growth of HIV/AIDS Therapeutic Markets frost.com Conference healthtech.com The largest HIV/AIDS website in the world aegis.com Profile marketguide.com Chart stockmaster.com Peptide nucleic acid Jump station horizonpress.com Combination Therapies for HCV home.texoma.com AIDS treatment news archive immunet.org Positive health news (1995) – scroll down a bit execpc.com Expanded Access Programs critpath.org Testimonial letter to Mr. Bregman at ADVR from 1992 hsph.harvard.edu Here is a REALLY old one…but interesting The following information is the Cover Story from PENNY STOCK MAGAZINE Volume 2, Number 4, dated April 1987 shoppingonthenet.com very LONG article (178 pages) on Hepatitis C– go to section IV.0.6 RETICULOSE members.bellatlantic.net From the Infectious Disease News – 1996 slackinc.com November 1999 Cambridge Healthtech Institute Chemokines Conference healthtech.com next conference - November 2000 in MacLean Va. American Society for Microbiology 21-May-98 New Non-Toxic Drug for AIDS newswise.com Product R – but it costs 2 bucks bioscorpio.com R NATUROPATHIC HERPES "CURE" FACTSHEET vers. 0.15 Apr. 20, 1999 Scroll waaaaaay down eff.org From Dr. Hirschman in 1996 and one from Friedland ncbi.nlm.nih.gov:80/entrez/query.fcgi?CMD=Display&DB=PubMed Centerwatch Clinical Trials Listing Service centerwatch.com Canine distemper virus patent - 5,807,840 bioinfo.com Patent 5,849,196 164.195.100.11 Patent 5,807,839 164.195.100.11 Reticulose mentioned in this article abcnews.go.com tess.uspto.gov Word Mark RETICULOSE Goods and Services IC 005. US 006 018 044 046 051 052. G & S: pharmaceutical peptide-nucleic acid solution for the treatment of viral diseases in humans, namely, influenza, viral hepatitis, mumps orchitis, viral pneumonia, mononucleosis, herpes, and human immunodeficiency virus. FIRST USE: 19921223. FIRST USE IN COMMERCE: 19921223 trademarks.uspto.gov trademark info newsday article newsday.com news article in The Journal News nyjournalnews.com AIDS Activists call for Fast Track prnewswire.com newsalert.com SECinfo.com - register for FREE and then search for Advanced Viral Research. All the SEC doecuments are there in a "clickable" format - very easy to read secinfo.com A reply to Aven1 webmd.lycos.com Peptide nucleic acids stimulate gamma interferon and inhibit the replication of the human immunodeficiency virus. infotrieve.com The latest medical news and information for patients or friends/parents of patients diagnosed with AIDS/HIV. pslgroup.com Everything that's old is new again - 1996 article slackinc.com a little info on Advanced Viral Research bioscorpio.com RETICULOSE Significant CD4 Increases Documented old article but it does list some Dr's who have used Reticulose in their practice scroll waaaaay down execpc.com Registrant: Advanced Viral Research (ADVIRAL-DOM) 1250 East Hallendale Beach Boulevard Suite 501 Hallendale, FL 33009 US Domain Name: adviral.com Registrant: Advanced Viral Research Corp (RETICULOSE-DOM) PO Box 3947 Sarasota, FL 34230-3947 us Domain Name: reticulose.com Registrant: Advanced Viral Research Corp. (ADVANCEDVIRAL-DOM) PO Box 3947 Sarasota, FL 34230-3947 US Domain Name: advancedviral.com Registrant: ADVANCED VIRAL RESEARCH (PEPTIGEN-DOM) 1250 Esat Hallendale Beach Blvd., Suite 5 HALLENDALE, FL 33009 US Domain Name: peptigen.com Registrant: ADVANCED VIRAL RESEARCH (PEPTIGENBIOPHARM-DOM) 1250 Esat Hallendale Beach Blvd., Suite 5 HALLENDALE, FL 33009 US Domain Name: peptigenbiopharm.com Registrant: INVERSIONES LATINAS (ADVANCEDVIRALRESEARCH-DOM) 709 WARBURTON AVE # 7C YONKERS, NY 10701 US Domain Name: advancedviralresearch.com